Location San Francisco, California, United States Regions San Francisco Bay Area, West Coast, Western US Gender Male Also Known As Dan Chao
LinkedIn View on LinkedIn X (Twitter) View on X
Daniel Chao is a neurotech entrepreneur, specializing in the development of deep technologies applied to the brain. Currently, Dan is CEO of System1 Biosciences, a venture-backed neurotherapeutics company that uses brain organoids and scaled biology to discovery new therapies for neuro and psychiatric disorders. Prior to System1, Dan was the
co-founder and CEO of Halo Neuroscience were he lead the development ofHalo Sport, the world's first neurostimulation system built specifically for athletes. Dan was the head of business development at NeuroPace, where he helped raise $250M in capital to develop the world's first closed-loop neuromodulation device, winning FDA approval for the treatment of epilepsy in a unanimous 13-0 vote. Before NeuroPace, Dan was a consultant at McKinsey & Company in the New York office, and he earned his M.D. and M.S. in neuroscience from Stanford University.
